A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: Clinical and biological features

AMALIA PALACIOS EITO2026-01-292026-01-29201510.1186/s12885-015-1053-z2-s2.0-84924076010https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25921Cancer ResearchGeneticsOncologyA randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: Clinical and biological featuresresearch article